Literature DB >> 6285715

Acyclovir in immunocompromised patients with cytomegalovirus disease. A controlled trial at one institution.

H H Balfour, B Bean, C D Mitchell, G W Sachs, J R Boen, C K Edelman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6285715     DOI： 10.1016/0002-9343(82)90099-7

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  11 in total

1.  Pharmacologic basis for high-dose oral acyclovir prophylaxis of cytomegalovirus disease in renal allograft recipients.

Authors:  C V Fletcher; J A Englund; C K Edelman; C R Gross; D L Dunn; H H Balfour
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

Review 2.  Antiviral therapy: current concepts and practices.

Authors:  B Bean
Journal:  Clin Microbiol Rev       Date:  1992-04       Impact factor: 26.132

3.  Cytomegalovirus infections in renal transplant recipients.

Authors:  T O Nunan; J E Banatvala
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-19

4.  Effect of 2'-nor-cyclic GMP against guinea pig cytomegalovirus infection.

Authors:  Z H Yang; H L Lucia; R L Tolman; R J Colonno; G D Hsiung
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

Review 5.  Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients.

Authors:  Daniel S Owers; Angela C Webster; Giovanni F M Strippoli; Kathy Kable; Elisabeth M Hodson
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

Review 6.  Antiherpes drugs: promises and pitfalls.

Authors:  E de Clercq
Journal:  Eur J Clin Microbiol       Date:  1984-04       Impact factor: 3.267

7.  Alpha-interferon administration in cytomegalovirus retinitis.

Authors:  S W Chou; J S Dylewski; M W Gaynon; P R Egbert; T C Merigan
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

8.  Prevention and treatment of cytomegalovirus infections with interferons and immune globulins.

Authors:  J D Meyers
Journal:  Infection       Date:  1985       Impact factor: 3.553

Review 9.  Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy.

Authors:  D M Richards; A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-11       Impact factor: 9.546

10.  9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication.

Authors:  A K Field; M E Davies; C DeWitt; H C Perry; R Liou; J Germershausen; J D Karkas; W T Ashton; D B Johnston; R L Tolman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.